Alvin Mondoh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alvin Mondoh has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Carel Wynand le Roux
University College Dublin, Dublin, Ireland
4 shared publications Francisca Contreras
Diabetes Complications Research Centre, Conway Institute of Biomedical and Biomolecular Research, University College Dublin, Dublin 4, Ireland
3 shared publications- Hilary C. Craig
Diabetes Complications Research Centre, Conway Institute of Biomedical and Biomolecular Research, University College Dublin, Dublin 4, Ireland
3 shared publications Michael Crotty
My Best Weight Clinic, Dublin, Ireland
2 shared publicationsDalal Alsaeed
DAFNE Unit, Clinical Care Research and Clinical Trials Unit, Dasman Diabetes Institute, Kuwait City, Kuwait, dasmaninstitute.org
1 shared publicationDherar Alroudhan
DAFNE Unit, Clinical Care Research and Clinical Trials Unit, Dasman Diabetes Institute, Kuwait City, Kuwait, dasmaninstitute.org
1 shared publication
Latest Publications
- Open Access
- 4 March 2026
- Published by Elsevier in Obesity Pillars
- Vol. 18, 100256
Factors influencing patient preferences for obesity pharmacotherapy: The triangulation of semi-structured interviews, photovoice study and focus group discussions
- 4 March 2026
- Published by Elsevier in Obesity Pillars
- Vol. 18, 100256
Open AccessFactors influencing patient preferences for obesity pharmacotherapy: The triangulation of semi-structured interviews, photovoice study and focus group discussions
- Open Access
- 27 November 2025
- Published by Elsevier in Obesity Pillars
- Vol. 17
Logistics, effectiveness, safety, and accessibility: Factors determining obesity medication patient preferences from a photovoice analysis
- 27 November 2025
- Published by Elsevier in Obesity Pillars
- Vol. 17
Open AccessLogistics, effectiveness, safety, and accessibility: Factors determining obesity medication patient preferences from a photovoice analysis
- Open Access
- 16 June 2025
- Published by Elsevier in Obesity Pillars
- Vol. 15, 100187
How do patients choose between obesity medications: A thematic analysis
- 16 June 2025
- Published by Elsevier in Obesity Pillars
- Vol. 15, 100187
Open AccessHow do patients choose between obesity medications: A thematic analysis
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Obesity
- Vol. 2025 (1)
Type 1 Diabetes Is a Barrier to Obesity Treatment: Patient Insights From a Mixed‐Methods Study
Background: Globally, many patients with Type 1 diabetes (T1D) are now characterized by excess adipose tissue and features of insulin resistance. In Kuwait, rapid urbanization, shifts in dietary patterns, and decreased physical activity have contributed to rising obesity prevalence in the general population. Objectives: We aimed to investigate the interplay between the diseases of obesity and T1D, examining patients’ perspectives on why they gained body weight, psychological aspects, and management challenges. Methods: A mixed‐methods approach was employed, encompassing quantitative analysis of body mass index (BMI) and lifestyle factors among 51 participants with T1D and obesity or obesity‐related complications and a thematic analysis of perceptions and experiences related to obesity and T1D using an online survey. Results: Participants identified lifestyle factors as the primary contributors to obesity, emphasizing the need for holistic interventions. About 56.8% of the participants perceived T1D as a barrier to obesity treatment. The qualitative analysis revealed four themes: 1) negative perceptions about obesity, 2) poor interface with healthcare professionals (HCPs), 3) lack of suggestions for improving obesity management, and 4) poor self‐image and awareness. This provided in‐depth insights into participants’ perceptions, worries, experiences, and suggestions for managing obesity in the context of T1D. Conclusions: This study contributes a nuanced understanding of obesity in patients with T1D, shedding light on the complexities beyond glycemic control. The findings emphasize the need for patient‐centered, multidisciplinary approaches that consider both medical and psychological aspects in the management of obesity within patients with T1D.
- 1 January 2025
- Published by Wiley in Journal of Obesity
- Vol. 2025 (1)
Open AccessType 1 Diabetes Is a Barrier to Obesity Treatment: Patient Insights From a Mixed‐Methods Study
Background: Globally, many patients with Type 1 diabetes (T1D) are now characterized by excess adipose tissue and features of insulin resistance. In Kuwait, rapid urbanization, shifts in dietary patterns, and decreased physical activity have contributed to rising obesity prevalence in the general population. Objectives: We aimed to investigate the interplay between the diseases of obesity and T1D, examining patients’ perspectives on why they gained body weight, psychological aspects, and management challenges. Methods: A mixed‐methods approach was employed, encompassing quantitative analysis of body mass index (BMI) and lifestyle factors among 51 participants with T1D and obesity or obesity‐related complications and a thematic analysis of perceptions and experiences related to obesity and T1D using an online survey. Results: Participants identified lifestyle factors as the primary contributors to obesity, emphasizing the need for holistic interventions. About 56.8% of the participants perceived T1D as a barrier to obesity treatment. The qualitative analysis revealed four themes: 1) negative perceptions about obesity, 2) poor interface with healthcare professionals (HCPs), 3) lack of suggestions for improving obesity management, and 4) poor self‐image and awareness. This provided in‐depth insights into participants’ perceptions, worries, experiences, and suggestions for managing obesity in the context of T1D. Conclusions: This study contributes a nuanced understanding of obesity in patients with T1D, shedding light on the complexities beyond glycemic control. The findings emphasize the need for patient‐centered, multidisciplinary approaches that consider both medical and psychological aspects in the management of obesity within patients with T1D.